Directory → Antineoplastic funds → Antineoplastic hormonal and hormone antagonists → Anandron
This page is translated automatically with a help of Google Translate

Anandron

See also Nilutamide

Roman name

Anandron

The composition and the form of

1 tablet contains nilutamida 50 mg; blistere in 15 pcs. , in box 6 blisters.

Indications

Metasteziruty cancer prostate gland.

Contraindications

Hypersensitivity, anaemia, a violation of the liver.

Side-Effects

Nausea, vomiting, violation ccomodation, intersticialny pulmonary syndrome, anaemia.

Patient interaction

Do effects propranolola, hlordiazepoksida, diazepam, theofillina by blocking their mikrosomalnoe oxidation; Incompatible with alcohol (antabus-effect).

Precautions

Treatment should be discontinued when the symptoms lungs, abdomen, unexplained pain, signs of jaundice, and growing level transaminaz serum (3 times compared to the norm), or reducing hemoglobin. There is a need to refrain from the use of alcohol and driving transport.

Dosing and Administration

Inside, in the 300 mg / day for 4 weeks, further supporting therapy, which is 150 mg / sutki.

Storage conditions

List B. The temperature is not above 25 ° C

Shelf life

3 years

The registration

011418/01-1999

All products of this group

0